We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

NICE:TASENICE Ltd. Analysis

Data as of 2026-03-11 - not real-time

$120.41

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

NICE Ltd. trades at $120.40, well below its DCF‑derived fair value of $158.65, implying roughly a 28% upside and positioning the stock as undervalued. The company’s forward PE of 9.68 and current PE of 12.45 are dramatically lower than the software industry average PE of 37, underscoring a strong value case. Margins remain healthy with a gross margin of 66% and operating margin of 22%, while ROE sits at 16%, indicating efficient capital use. Technicals are supportive: the price is above both the 20‑day (115.3) and 50‑day (114.1) SMAs, the MACD histogram is positive and the signal is bullish, and the RSI of 55 suggests momentum is neither overbought nor oversold. However, volume is on a decreasing trend, which tempers short‑term enthusiasm. Recent news of new AI‑driven risk tools from the Actimize and Cognigy units reinforces the long‑term growth narrative, especially in the high‑margin financial‑crime compliance segment.
The stock’s beta of ~0.85 and 30‑day volatility of 61% point to moderate market sensitivity, while a solid balance sheet—$417 M cash versus $88 M debt—provides a cushion against downturns. Analysts’ consensus is a “Buy” with a median target of $150, further validating upside potential. Given the blend of attractive valuation, robust fundamentals, and strategic AI expansion, the investment case is compelling across horizons, though liquidity concerns from declining volume merit monitoring.

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 7/10

Key Factors

  • Bullish MACD and price above short‑term SMAs
  • Substantial valuation gap to DCF fair value
  • Decreasing volume introduces short‑term execution risk

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Strong cash flow generation and low debt
  • Analyst consensus buy with median target $150
  • Revenue growth of ~9% and expanding AI‑driven SaaS offerings

Long Term

> 3 years
Positive
Model confidence: 9/10

Key Factors

  • Strategic launch of AI risk‑management platforms
  • High‑margin recurring revenue from financial‑crime compliance
  • Global customer base reducing reliance on any single geography

Key Metrics & Analysis

Financial Health

Revenue Growth9.00%
Profit Margin20.78%
P/E Ratio12.5
ROE16.37%
ROA7.87%
Debt/Equity2.29
P/B Ratio1.9
Op. Cash Flow$716.5M
Free Cash Flow$457.3M
Industry P/E37.0

Technical Analysis

TrendNeutral
RSI54.8
Support$94.65
Resistance$135.55
MA 20$115.31
MA 50$114.07
MA 200$134.53
MACDBullish
VolumeDecreasing
Fear & Greed Index77.93

Valuation

Fair Value$158.65
Target Price$154.27
Upside/Downside28.12%
GradeUndervalued
TypeBlend

Risk Assessment

Beta0.85
Volatility60.87%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.